Antibodies to human angiopoietin-like protein 3: a patent evaluation of WO2012174178
{{output}}
The patent WO2012174178 claims the effect of a fully human antibody or antigen-binding fragment of a human antibody which specifically binds and neutralizes, inhibits, blocks, abrogates, reduces or interferes with the activity of human angiopoietin-like protei... ...
